Eric Burak
2019
In 2019, Eric Burak earned a total compensation of $483.7K as Chief Scientific Officer at Fusion Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $90,129 |
|---|---|
| Option Awards | $99,570 |
| Salary | $293,610 |
| Other | $425 |
| Total | $483,734 |
Burak received $293.6K in salary, accounting for 61% of the total pay in 2019.
Burak also received $90.1K in non-equity incentive plan, $99.6K in option awards and $425 in other compensation.
Rankings
In 2019, Eric Burak's compensation ranked 11,859th out of 13,971 executives tracked by ExecPay. In other words, Burak earned more than 15.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,859 out of 13,971 | 15th |
Division Manufacturing | 4,802 out of 5,701 | 16th |
Major group Chemicals And Allied Products | 1,897 out of 2,200 | 14th |
Industry group Drugs | 1,635 out of 1,886 | 13th |
Industry Biological Products, Except Diagnostic Substances | 350 out of 389 | 10th |
Source: SEC filing on April 27, 2021.
Burak's colleagues
We found two more compensation records of executives who worked with Eric Burak at Fusion Pharmaceuticals in 2019.